Back to Results
First PageMeta Content
Endocrine system / Health / Clinical research / European Medicines Agency / Pharmaceutical industry / Growth hormone treatment / Committee for Medicinal Products for Human Use / Growth hormone / Saizen / Growth hormones / Eli Lilly and Company / Medicine


European Medicines Agency confirms positive benefit-risk balance of somatropin-containing medicines
Add to Reading List

Document Date: 2013-07-21 06:24:50


Open Document

File Size: 56,97 KB

Share Result on Facebook
UPDATE